About NAPIGEN
NAPIGEN is an Agriculture company based in Wilmington (United States) founded in 2016 by Roger Wyse. Hybrid crop plants are developed using genome engineering techniques. NAPIGEN has raised $8 million across 5 funding rounds from investors including HHS, RA Capital and Grantham Foundation. The company has 13 employees. NAPIGEN offers products and services including Genome Editing Services. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Seeds. Its legal entity is NAPIGEN, INC. Its competitors include Corteva Agriscience and PowerPollen; 1 of its 2 listed competitors has raised funding.
Company details
NAPIGEN was founded in 2016 and is based in Wilmington, United States. Non-GMO hybrid seeds for autogamous cereals are developed by the company to improve crop yields through hybrid vigor. Proprietary hybridization and genome engineering methods are utilized in operations within the agritech sector. Focus is placed on enhancing agricultural productivity without genetic modification.
- Headquarters Wilmington, United States
- Employees 13
- Founders Roger Wyse
- SectorsAgriculture
- Email••••••••
- Phone•••• ••••
- Website napigen.com
- Social LinkedIn X
- Legal Name Napigen, Inc.
- Total Equity Funding$8M (USD)
in 5 rounds
- Latest Funding Round$175K (USD), Grant
Jul 2024
- InvestorsHHS
& 6 more
- Employee Count13
Products & Services of NAPIGEN
NAPIGEN offers a comprehensive portfolio of products and services, including Genome Editing Services.
Offers tools for editing mitochondrial and chloroplast genomes in research.
Funding Insights of NAPIGEN
NAPIGEN has successfully raised a total of $8M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $175 thousand completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8M
- Total Rounds 5
- Last Round Grant — $175,000
- First Round $100,000
(Apr 2018)
- Investors Count 7
All 5 funding rounds of NAPIGEN with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $175,000 | Grant | – | – | |
| Jul 2022 | $7.9M | Seed | – | Grantham Foundation, RA Capital Management | |
| Jun 2022 | $225,000 | Grant | – | – | |
| Sep 2020 | $100,000 | Grant | – | – | |
| Apr 2018 | $100,000 | Seed | – | THRIVE | – |
7 investors in total: 7 institutional.
Investors in NAPIGEN
NAPIGEN has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, RA Capital and Grantham Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage bioscience entrepreneurs are supported through venture capital. | 2020 | marsbio.vc | Los Angeles, United States | |
Food and agtech startups are accelerated by THRIVE programs. | thriveagrifood.com | Los Gatos, United States | ||
Early-stage science-driven companies are supported through venture capital investments. | breakoutlabs.org | |||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| granthamfoundation.org | ||||
RA Capital is engaged in evidence-based investing in healthcare and life sciences. | 2004 | racap.com | Boston, United States | |
| umdf.org |
Investor details for NAPIGEN
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NAPIGEN
5 people are tracked at NAPIGEN (2 in leadership, 3 in team); the tracked headcount is 13.
| Name | Role | Group |
|---|---|---|
Roger Wyse | Co-Founder | Leadership |
DILBAG MULTANI | Research Director - Plant Genetics | Leadership |
Nicole Rummel | Research Scientist | Team |
Kamal Bhattarai | Research Manager | Team |
Sachie Kimura | Research Fellow | Team |
Complete people profiles for NAPIGEN
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NAPIGEN
3 dated milestones of NAPIGEN across 8 years, from founding to its latest funding, stage changes and deals.
- Founded NAPIGEN is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Grant, of $175K.
Competitors of NAPIGEN
NAPIGEN has 2 listed competitors in our database, 1 of them funded. They include Corteva Agriscience and PowerPollen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| corteva.com | 2017 | Wilmington, United States | 22,500 | Manufacturer and supplier of agricultural farm inputs | ||
| powerpollen.com | 2015 | Ankeny, United States | $38.4M | Hybrid corn seeds are produced and supplied using pollen technology. |
Detailed competitors of NAPIGEN
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Crop Tech & Equipment
3 companies that operate in the same segment as NAPIGEN (Crop Tech & Equipment) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of plant-based food ingredients | 2012 | St. Louis, Missouri, United States | USD 406.99 M | USD 470 M | ||
Robotic equipment for automating weeding on vegetable farms is developed. | 2016 | San Francisco, California, United States | USD 139.96 M | 73 | ||
Provider of farmers networking platform | 2014 | San Carlos, California, United States | USD 981.09 M | 808 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Napigen
Complete news archive for NAPIGEN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NAPIGEN
NAPIGEN was founded in 2016 and raised its 1st funding round 2 years after it was founded.
NAPIGEN is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
NAPIGEN is a funded company, having raised a total of $8M across 5 funding rounds to date. The company's 1st funding round was a Seed of $100K, raised on Apr 2018.
NAPIGEN has 13 employees.
NAPIGEN was founded in 2016 and is based in Wilmington, United States. Non-GMO hybrid seeds for autogamous cereals are developed by the company to improve crop yields through hybrid vigor. Proprietary hybridization and genome engineering methods are utilized in operations within the agritech sector. Focus is placed on enhancing agricultural productivity without genetic modification.
NAPIGEN's top competitors include Corteva Agriscience and PowerPollen.
NAPIGEN offers Genome Editing Services.
NAPIGEN has 7 investors. Key investors include HHS, RA Capital, Grantham Foundation, Umdf, and MarsBio.
NAPIGEN operates through Napigen, Inc..